Could a pill curb alcohol cravings? new trial seeks answers
NCT ID NCT07325266
First seen Jan 10, 2026 · Last updated Jun 13, 2026 · Updated 21 times
Summary
This study tests whether the drug apremilast can reduce cravings for alcohol in people with moderate to severe alcohol use disorder. About 100 adults who want to cut back or quit drinking will take either a low or high dose of apremilast or a placebo daily for two weeks. Researchers will measure changes in cravings, drinking behavior, mood, and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California
RECRUITINGLos Angeles, California, 90095, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Colorado
RECRUITINGAurora, Colorado, 80045, United States
Contact
Contact Email: •••••@•••••
-
University of Virginia
RECRUITINGCharlottesville, Virginia, 22911, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.